Complete NERV Stock Valuation Analysis
Comprehensive intrinsic value analysis using 3 different methodologies
NERV Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 7 peer companies in Healthcare
P/E Ratio
$1.87
+0.0%
Peer Median: 9.8x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.03
-98.6%
Peer Median: 4.3x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for NERV's business model and current situation.
Multiple Comparison
| Multiple | NERV Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | 9.8x | 9.8x | 9.8x | 0.0% | Fair Value |
| EV/EBITDA | -1.4x | 0.0x | 0.0x | -Infinity% | Undervalued |
| P/S Ratio | 309.8x | 4.3x | 5.6x | 7064.8% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.30B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 59.9x | |
| $0.01B | 9.8x | -1.4x | 309.8x | |
| $0.01B | 0.0x | 0.0x | 0.2x | |
| $0.01B | 0.0x | 0.0x | 12.4x | |
| $0.01B | 0.0x | 0.0x | 4.3x |
NERV Graham Intrinsic Value
Growth-adjusted intrinsic value with two formula variants
Formula Selection
V = EPS × (8.5 + 2g)
Graham's original P/E shortcut for growth, no interest-rate adjustment
V = [EPS × (8.5 + 2g) × 4.4] / Y
Graham's 1974 refinement: adds rate-environment sensitivity
Active Formula: Base-Growth
0.19 × (8.5 + 2 × 8.0%)
Input Data & Growth Assumptions
Current EPS (TTM)$0.19
Latest 10-K • 2024-12-31T00:00:00
No positive historical growth rates available.
Graham's formula is designed for growing companies. Use the custom input below with a conservative positive growth estimate (5-10%).
Custom
%
Enter a positive growth rate estimate (0-50%)
Graham Intrinsic Value Result
$4.66
Intrinsic Value
$1.87
Current Price
+149.0%
Upside/Downside
Base Formula
Growth: 8.0%
NERV Peter Lynch Fair Value
Growth-based valuation using PEG ratio analysis for growth stocks
Fair Value Calculation
EPS (TTM)$0.19
Latest 10-K • 2024-12-31T00:00:00
No positive historical growth rates available. Using custom growth rate slider.
10.0%
1%50%
Fair Value Formula: EPS × Growth Rate
$0.19 × 10.0% = $1.90
$1.90
Fair Value
$1.87
Current Price
+1.6%
Upside/Downside
PEG Analysis
9.8x
Current P/E
10.0%
Growth Rate
0.98
PEG Ratio (P/E ÷ Growth Rate)
Undervalued
PEG Ratio Interpretation:
• PEG < 1.0: Undervalued (growth exceeds P/E)
• PEG = 1.0: Fairly valued (ideal Lynch ratio)
• PEG > 1.5: Overvalued (paying premium for growth)
Peter Lynch's Rule:
"The P/E ratio of any company that's fairly priced will equal its growth rate." A stock with 15% growth should trade at a P/E of 15 (PEG = 1.0).